Literature DB >> 23243386

Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.

Regine Choe1, Turgut Durduran.   

Abstract

Recent advances in the use of diffuse optical techniques for monitoring the hemodynamic, metabolic and physiological signatures of the neoadjuvant breast cancer therapy effectiveness is critically reviewed. An extensive discussion of the state-of-theart diffuse optical mammography is presented alongside a discussion of the current approaches to breast cancer therapies. Overall, the diffuse optics field is growing rapidly with a great deal of promise to fill an important niche in the current approaches to monitor, predict and personalize neoadjuvant breast cancer therapies.

Entities:  

Year:  2011        PMID: 23243386      PMCID: PMC3521564          DOI: 10.1109/JSTQE.2011.2177963

Source DB:  PubMed          Journal:  IEEE J Sel Top Quantum Electron        ISSN: 1077-260X            Impact factor:   4.544


  156 in total

Review 1.  New therapeutic agents targeting the epidermal growth factor receptor.

Authors:  J Baselga
Journal:  J Clin Oncol       Date:  2000-11-01       Impact factor: 44.544

2.  Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma.

Authors:  A Makris; T J Powles; S Kakolyris; M Dowsett; S E Ashley; A L Harris
Journal:  Cancer       Date:  1999-05-01       Impact factor: 6.860

3.  Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: a case study.

Authors:  Natasha Shah; Jessica Gibbs; Dulcy Wolverton; Albert Cerussi; Nola Hylton; Bruce J Tromberg
Journal:  J Biomed Opt       Date:  2005 Sep-Oct       Impact factor: 3.170

4.  Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging.

Authors:  L Esserman; N Hylton; L Yassa; J Barclay; S Frankel; E Sickles
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

5.  Diffuse Optics for Tissue Monitoring and Tomography.

Authors:  T Durduran; R Choe; W B Baker; A G Yodh
Journal:  Rep Prog Phys       Date:  2010-07

6.  Computer aided automatic detection of malignant lesions in diffuse optical mammography.

Authors:  David R Busch; Wensheng Guo; Regine Choe; Turgut Durduran; Michael D Feldman; Carolyn Mies; Mark A Rosen; Mitchell D Schnall; Brian J Czerniecki; Julia Tchou; Angela DeMichele; Mary E Putt; Arjun G Yodh
Journal:  Med Phys       Date:  2010-04       Impact factor: 4.071

7.  Time-domain optical mammography SoftScan: initial results.

Authors:  Xavier Intes
Journal:  Acad Radiol       Date:  2005-08       Impact factor: 3.173

8.  Standardized platform for coregistration of nonconcurrent diffuse optical and magnetic resonance breast images obtained in different geometries.

Authors:  Fred S Azar; Kijoon Lee; Ali Khamene; Regine Choe; Alper Corlu; Soren D Konecky; Frank Sauer; Arjun G Yodh
Journal:  J Biomed Opt       Date:  2007 Sep-Oct       Impact factor: 3.170

9.  Three-dimensional time-resolved optical mammography of the uncompressed breast.

Authors:  Louise C Enfield; Adam P Gibson; Nicholas L Everdell; David T Delpy; Martin Schweiger; Simon R Arridge; Caroline Richardson; Mohammad Keshtgar; Michael Douek; Jeremy C Hebden
Journal:  Appl Opt       Date:  2007-06-10       Impact factor: 1.980

10.  Due to intravascular multiple sequential scattering, Diffuse Correlation Spectroscopy of tissue primarily measures relative red blood cell motion within vessels.

Authors:  Stefan A Carp; Nadàege Roche-Labarbe; Maria-Angela Franceschini; Vivek J Srinivasan; Sava Sakadžić; David A Boas
Journal:  Biomed Opt Express       Date:  2011-06-24       Impact factor: 3.732

View more
  28 in total

1.  Longitudinal optical monitoring of blood flow in breast tumors during neoadjuvant chemotherapy.

Authors:  J M Cochran; S H Chung; A Leproux; W B Baker; D R Busch; A M DeMichele; J Tchou; B J Tromberg; A G Yodh
Journal:  Phys Med Biol       Date:  2017-04-12       Impact factor: 3.609

2.  Wearable near-infrared optical probe for continuous monitoring during breast cancer neoadjuvant chemotherapy infusions.

Authors:  Fei Teng; Timothy Cormier; Alexis Sauer-Budge; Rachita Chaudhury; Vivian Pera; Raeef Istfan; David Chargin; Samuel Brookfield; Naomi Yu Ko; Darren M Roblyer
Journal:  J Biomed Opt       Date:  2017-01-01       Impact factor: 3.170

3.  Pre-clinical longitudinal monitoring of hemodynamic response to anti-vascular chemotherapy by hybrid diffuse optics.

Authors:  Parisa Farzam; Johannes Johansson; Miguel Mireles; Gabriela Jiménez-Valerio; Mar Martínez-Lozano; Regine Choe; Oriol Casanovas; Turgut Durduran
Journal:  Biomed Opt Express       Date:  2017-04-19       Impact factor: 3.732

4.  Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system.

Authors:  Stefan A Carp; Amir Y Sajjadi; Christy M Wanyo; Qianqian Fang; Michelle C Specht; Lidia Schapira; Beverly Moy; Aditya Bardia; David A Boas; Steven J Isakoff
Journal:  Biomed Opt Express       Date:  2013-11-22       Impact factor: 3.732

5.  Heterodyne frequency-domain multispectral diffuse optical tomography of breast cancer in the parallel-plane transmission geometry.

Authors:  H Y Ban; M Schweiger; V C Kavuri; J M Cochran; L Xie; D R Busch; J Katrašnik; S Pathak; S H Chung; K Lee; R Choe; B J Czerniecki; S R Arridge; A G Yodh
Journal:  Med Phys       Date:  2016-07       Impact factor: 4.071

6.  Recipes for diffuse correlation spectroscopy instrument design using commonly utilized hardware based on targets for signal-to-noise ratio and precision.

Authors:  Lorenzo Cortese; Giuseppe Lo Presti; Marco Pagliazzi; Davide Contini; Alberto Dalla Mora; Hamid Dehghani; Fabio Ferri; Jonas B Fischer; Martina Giovannella; Fabrizio Martelli; Udo M Weigel; Stanislaw Wojtkiewicz; Marta Zanoletti; Turgut Durduran
Journal:  Biomed Opt Express       Date:  2021-05-11       Impact factor: 3.732

7.  The LUCA device: a multi-modal platform combining diffuse optics and ultrasound imaging for thyroid cancer screening.

Authors:  Lorenzo Cortese; Giuseppe Lo Presti; Marta Zanoletti; Gloria Aranda; Mauro Buttafava; Davide Contini; Alberto Dalla Mora; Hamid Dehghani; Laura Di Sieno; Sixte de Fraguier; Felicia A Hanzu; Mireia Mora Porta; An Nguyen-Dinh; Marco Renna; Bogdan Rosinski; Mattia Squarcia; Alberto Tosi; Udo M Weigel; Stanislaw Wojtkiewicz; Turgut Durduran
Journal:  Biomed Opt Express       Date:  2021-05-14       Impact factor: 3.732

8.  Blood flow reduction in breast tissue due to mammographic compression.

Authors:  David R Busch; Regine Choe; Turgut Durduran; Daniel H Friedman; Wesley B Baker; Andrew D Maidment; Mark A Rosen; Mitchell D Schnall; Arjun G Yodh
Journal:  Acad Radiol       Date:  2014-02       Impact factor: 3.173

9.  Chemotherapeutic drug-specific alteration of microvascular blood flow in murine breast cancer as measured by diffuse correlation spectroscopy.

Authors:  Gabriel Ramirez; Ashley R Proctor; Ki Won Jung; Tong Tong Wu; Songfeng Han; Russell R Adams; Jingxuan Ren; Daniel K Byun; Kelley S Madden; Edward B Brown; Thomas H Foster; Parisa Farzam; Turgut Durduran; Regine Choe
Journal:  Biomed Opt Express       Date:  2016-08-24       Impact factor: 3.732

10.  Noncontact diffuse correlation tomography of human breast tumor.

Authors:  Lian He; Yu Lin; Chong Huang; Daniel Irwin; Margaret M Szabunio; Guoqiang Yu
Journal:  J Biomed Opt       Date:  2015-08       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.